Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2005
Business Overview: Stepan Company manufactures and markets specialty chemicals, primarily surfactants, polymers, and specialty products. The company operates globally with significant segments in the United States, Europe, and Latin America.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended June 30, 2005 |
3 Months Ended June 30, 2004 |
6 Months Ended June 30, 2005 |
6 Months Ended June 30, 2004 |
|---|---|---|---|---|
| Net Sales | $278,353 | $236,347 | $542,605 | $457,734 |
| Gross Profit | $34,703 | $30,496 | $64,519 | $60,148 |
| Operating Income | $10,466 | $7,115 | $17,350 | $15,118 |
| Net Income | $6,177 | $3,802 | $9,421 | $7,832 |
| Diluted EPS | $0.64 | $0.39 | $0.97 | $0.81 |
| Cash from Operations (6mo) | ($4,345) | $7,197 | ($4,345) | $7,197 |
| Total Debt (Long-term + Current) | $133,433 | N/A | $133,433 | N/A |
| Cash & Equivalents | $2,914 | N/A | $2,914 | N/A |
Note: Debt figures for 2005 are derived from the balance sheet (Current maturities $17,826 + Long-term debt $115,607). 2004 comparative debt figures are not explicitly aggregated in the text provided.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18% ($42.0 million) for the quarter and 19% ($84.9 million) for the six months. Growth was driven by a 9% increase in sales volume and higher selling prices passed through to offset rising raw material costs.
- Profitability: Net income rose 62% for the quarter and 20% for the six months. This was primarily due to a strong performance in the Polymers segment, which saw operating income increase 135% for the quarter.
- Segment Performance:
- Polymers: Sales up 33% (quarter) and 41% (six months). Gross profit improved significantly due to price increases and a large polyurethane systems order.
- Surfactants: Sales up 14% (quarter) and 14% (six months), driven by biodiesel demand and foreign volume. However, operating income declined 47% (quarter) and 36% (six months) due to unfavorable sales mix, rising raw material costs, and higher manufacturing expenses.
- Specialty Products: Sales increased 8% for the quarter but declined 11% for the six months due to lower volumes in food and flavoring lines.
- Cash Flow: Operating cash flow turned negative ($4.3 million used) for the first half of 2005 compared to a positive $7.2 million in 2004. This was caused by a $34.1 million increase in working capital requirements, specifically higher inventories and lower accounts payable.
- Debt Levels: Total consolidated debt increased by $21.4 million to $133.4 million as of June 30, 2005, to fund working capital and capital expenditures.
Guidance, Outlook, and Risks
- Outlook: Management expects polymer earnings improvements to continue. Surfactant sales mix is projected to improve, and biodiesel demand remains strong. European surfactant earnings are forecast to improve in the second half of 2005 following a competitor's plant shutdown in the UK.
- Capital Expenditures: Expected to range between $42.0 million and $49.0 million for the full year 2005, compared to $33.8 million in 2004.
- Environmental & Legal Contingencies: The company faces potential liabilities at 21 waste disposal sites. The estimated range of possible losses is $8.4 million to $40.2 million. The company has accrued $18.5 million as of June 30, 2005. Specific sites include Maywood (NJ), Ewan and D'Imperio (NJ), and Wilmington (MA).
- Market Risks: Key risks include the ability to pass on raw material price increases, foreign currency fluctuations, and competitive pressures. The company noted that high raw material costs and excess industry capacity in Europe have made price recovery difficult.
- Accounting Changes: Effective January 1, 2005, the company began charging corporate manufacturing expenses against reportable segments, changing the comparability of segment operating income.
Investor Verification Checklist
- Working Capital Trends: Verify the sustainability of the $34.1 million cash outflow for working capital and the strategy behind inventory buildup.
- Raw Material Cost Pass-Through: Assess the company's ability to maintain price increases in the Surfactants segment, particularly in the UK where competition is intense.
- Environmental Reserves: Review the $18.5 million accrued liability against the $8.4M–$40.2M estimated loss range for potential future adjustments.
- Debt Covenants: Confirm continued compliance with loan agreements, noting the recent waiver of certain ratios for Stepan Europe in 2004.
- Segment Accounting: Ensure comparisons with prior years account for the 2005 change in how corporate manufacturing expenses are allocated to segments.